Calcium Gluconate Administration Protocols
For acute symptomatic hypocalcemia, administer 1 gram (90 mg elemental calcium) of IV calcium gluconate as a bolus over 10-20 minutes via a secure large-bore IV with continuous cardiac monitoring, followed by a continuous infusion of 10 grams in 1 liter of D5W or normal saline at 100 mL/hour, titrated to serum calcium levels. 1
Acute Symptomatic Hypocalcemia
Initial Bolus Administration
- Dose: 90-180 mg elemental calcium (1-2 grams calcium gluconate) 1, 2
- Route: IV via secure, large-bore needle in durable vein 1
- Rate: Over 10-20 minutes; DO NOT exceed 200 mg/minute in adults or 100 mg/minute in pediatrics 2
- Monitoring: Continuous cardiac monitoring during administration 1
- Critical warning: Rapid infusion can cause cardiac arrest 1
Indications for IV Calcium (Regardless of Calcium Level)
- Seizures, laryngospasm, bronchospasm, or severe tetany 1
- Prolonged QTc (>0.45s in men, >0.47s in women) 1
- Albumin-corrected calcium <7.5 mg/dL (1.9 mmol/L) 1
- Inability to take oral supplements 1
Continuous Infusion Protocol
After initial bolus, prepare continuous infusion:
- Preparation: Mix 10 ampules (900 mg elemental calcium) in 1 liter D5W or normal saline 1
- Starting rate: 100 mL/hour 1
- Titration: Adjust based on serum calcium levels (albumin-corrected or ionized) 1
- Monitoring frequency: Every 6 hours initially, then daily until stable 1
- Target: Low-normal calcium range 1
- Expected effect: 15 mg/kg elemental calcium over 4-6 hours increases serum calcium by 0.5-0.75 mmol/L 1
Critical incompatibilities: Do NOT mix with bicarbonate or phosphate-containing solutions (forms insoluble calcium salts) 1, 2
Concurrent Therapy
Simultaneously initiate:
- Calcitriol: 0.25-0.5 μg PO twice daily, OR
- Alfacalcidol: 0.5 μg PO daily 1
- Correct hypomagnesemia if present (essential for effective hypocalcemia treatment) 1
Life-Threatening Hyperkalemia
For hyperkalemia with ECG changes or potassium ≥6.5 mmol/L, immediately administer 10 mL of 10% calcium gluconate (or 5-10 mL calcium chloride) IV over 2-5 minutes with continuous cardiac monitoring to stabilize cardiac membranes. 3, 4
Membrane Stabilization
- Calcium gluconate 10%: 15-30 mL (1,500-3,000 mg) IV over 2-5 minutes 3, 4
- Indication: ECG changes OR potassium ≥6.5 mmol/L 5, 3
- Onset: 1-3 minutes 6
- Monitoring: Continuous ECG during administration 5, 3
Important distinction: Calcium gluconate is preferred over calcium chloride due to lower risk of tissue necrosis if extravasation occurs 1. However, calcium chloride provides more elemental calcium per volume (272 mg vs 90 mg per gram) 1.
Concurrent Potassium-Lowering Therapy
After membrane stabilization, immediately initiate:
- Insulin + glucose: 10 units regular insulin + 50 mL D50 IV over 15-30 minutes 3, 4
- Nebulized albuterol: 10-20 mg over 15 minutes 3, 4
- Sodium bicarbonate: 50 mEq IV over 5 minutes (only if metabolic acidosis present) 5, 3
Calcium Channel Blocker Overdose
For calcium channel blocker toxicity, administer 2,000 mg (20 mL of 10%) calcium chloride or 6,000 mg (60 mL of 10%) calcium gluconate IV, followed by continuous infusion of 20-40 mg/kg/hour calcium chloride (or 60-120 mg/kg/hour calcium gluconate), titrated to blood pressure with goal ionized calcium 1.5-2 times upper limit of normal. 4, 7, 8
Initial Bolus
- Calcium chloride 10%: 2,000 mg (20 mL) IV 4
- Provides 28 mEq elemental calcium 4
- OR Calcium gluconate 10%: 6,000 mg (60 mL) IV 4
- Provides 28 mEq elemental calcium 4
Continuous Infusion
- Calcium chloride: 20-40 mg/kg/hour (0.28-0.56 mEq/kg/hour) 4
- OR Calcium gluconate: 60-120 mg/kg/hour (0.28-0.56 mEq/kg/hour) 4
- Titration target: Blood pressure response 4, 7
- Maximum ionized calcium: 1.5-2 times upper limit of normal 4
- Route: Central line preferred, especially in children 4
Key consideration: Calcium alone is often insufficient for severe CCB toxicity; high-dose insulin euglycemia therapy is the primary treatment 7, 8. Calcium serves as adjunctive therapy 7, 8.
Severe Hypermagnesemia
For severe hypermagnesemia with cardiac manifestations, administer calcium gluconate using the same protocol as hyperkalemia: 10-30 mL of 10% calcium gluconate IV over 2-5 minutes with cardiac monitoring. 3, 9, 4
Dosing
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes 3, 4
- OR Calcium chloride 10%: 5-10 mL IV over 2-5 minutes 3, 4
- Pediatric dose: 20 mg/kg calcium chloride (0.2 mL/kg of 10% solution) OR 60 mg/kg calcium gluconate 9
Tumor Lysis Syndrome with Hypocalcemia
In tumor lysis syndrome, treat hypocalcemia with calcium gluconate ONLY when symptomatic (paresthesias, tetany) AND calcium ≤7 mg/dL or ionized calcium ≤0.8 mmol/L (≤3.2 mg/dL), repeating every hour until symptoms resolve. 5
Critical Exception
When hyperkalemia coexists with hypocalcemia in tumor lysis syndrome, manage hypocalcemia aggressively with calcium gluconate because the risk of cardiac dysrhythmias and sudden death from hyperkalemia outweighs the risk of calcium phosphate precipitation. 5
Standard Approach (No Hyperkalemia)
- Do NOT treat asymptomatic hypocalcemia 5
- Rationale: Risk of calcium phosphate crystal precipitation causing AKI or cardiac dysrhythmias 5
- Treatment threshold: Symptomatic AND calcium ≤7 mg/dL or ionized calcium ≤0.8 mmol/L 5
- Dosing: Calcium gluconate infusion, repeated hourly until symptoms resolve 5
With Concomitant Hyperphosphatemia
Use the lowest dose of calcium sufficient to relieve symptoms to minimize calcium phosphate precipitation risk 5
Chronic Hypocalcemia (Hypoparathyroidism)
For chronic hypocalcemia management, target low-normal albumin-corrected serum calcium with oral calcium supplements (1,000-3,000 mg elemental calcium daily in divided doses) plus calcitriol (0.25-0.5 μg twice daily), monitoring serum calcium every 3-12 months and 24-hour urine calcium every 6-24 months. 1
Monitoring Schedule
- Stable patients: Serum calcium, albumin, phosphorus, magnesium, eGFR every 3-12 months 1
- Unstable patients: Recheck serum calcium within several days after medication changes 1
- 24-hour urine calcium: Every 6-24 months 1
- Target urine calcium: <250 mg/24h (women), <300 mg/24h (men) 1
Limitation: The FDA label specifies that safety of calcium gluconate injection for long-term use has not been established 2. Chronic management relies on oral calcium and vitamin D supplementation.
Pediatric Considerations
Neonates and Infants
- Maximum infusion rate: 100 mg/minute (vs 200 mg/minute in adults) 2
- Hyperkalemia dose: 20 mg/kg calcium chloride (0.2 mL/kg of 10%) OR 60 mg/kg calcium gluconate 9
- Contraindication: Concomitant ceftriaxone in neonates ≤28 days (risk of fatal ceftriaxone-calcium precipitates) 2
Older Children
- CCB overdose: Same weight-based dosing as adults (20-40 mg/kg/hour calcium chloride) 4
- Central line preferred for calcium chloride administration due to severe tissue injury risk with extravasation 9, 4
Critical Safety Warnings
Extravasation and Tissue Necrosis
Calcium gluconate is strongly preferred over calcium chloride for peripheral IV administration due to significantly lower risk of severe skin and soft tissue necrosis if extravasation occurs. 1, 9, 2
- Use secure, large-bore IV in durable vein 1
- Central line preferred for calcium chloride, especially in children 9, 4
- If extravasation occurs: Immediately discontinue infusion and treat as needed 1, 2
- Calcinosis cutis can occur even without extravasation 1, 2
Cardiac Glycoside Interaction
Avoid calcium gluconate in patients receiving digoxin or other cardiac glycosides; if unavoidable, administer slowly in small amounts with continuous ECG monitoring. 2
Rapid Administration Risks
Drug Incompatibilities
Never mix calcium gluconate with:
- Ceftriaxone (fatal precipitates, especially in neonates) 2
- Bicarbonate-containing solutions 1, 2
- Phosphate-containing solutions 1, 2
- Minocycline (calcium complexes and inactivates it) 2
Renal Impairment
In patients with renal impairment, initiate at the lowest recommended dose and monitor serum calcium every 4 hours. 2
Preparation and Dilution
For Bolus Administration
- Dilute dose in D5W or normal saline to concentration of 10-50 mg/mL 2
- Administer over 10-20 minutes 2
For Continuous Infusion
- Dilute in D5W or normal saline to concentration of 5.8-10 mg/mL 2
- Use immediately after preparation 2
Visual Inspection
- Solution should be clear and colorless to slightly yellow 2
- Do not use if particulate matter or discoloration present 2
Common Pitfalls
Using calcium chloride peripherally in children: High risk of severe tissue necrosis; use calcium gluconate or central line 9, 4
Treating asymptomatic hypocalcemia in tumor lysis syndrome: Increases calcium phosphate precipitation risk without benefit 5
Mixing calcium with bicarbonate or phosphate: Forms insoluble precipitates 1, 2
Rapid infusion: Can cause cardiac arrest; always administer slowly with cardiac monitoring 1, 2
Forgetting to correct hypomagnesemia: Hypocalcemia cannot be effectively treated until magnesium is normalized 1
Administering ceftriaxone with calcium in neonates: Contraindicated due to fatal precipitate formation 2
Inadequate monitoring during continuous infusion: Check calcium every 1-4 hours during continuous infusion, not just daily 2